Hepatitis Diagnostic Test Market Analysis Report, By Diagnostic Tests {Blood Tests (Liver Function Assays, Immunoassays & Nucleic Acid Assays), Imaging Tests & Liver Biopsy}, By Region, And Segment Forecasts, 2014 - 2025

January 2018 | 90 pages | ID: H8665D09FFEEN
Grand View Research, Inc.

Abstracts

The global hepatitis diagnostics test market is expected to reach USD 6.9 billion by 2025, according to a new report by Grand View Research, Inc. The rise in cases of hepatitis A, B & C is prominent as compared to D & E. World Health Organization (WHO), reports state 90% of children (before the age of 10 years), in developing countries are infected with hepatitis A virus. The reports by the WHO also states that 257 million people were suffering from hepatitis B virus infection, and 71 million people were affected by the hepatitis C in 2016.

The government, NGOs and non-profitable organizations play an important role in creating awareness of diseases by providing correct information about the condition, symptoms and detection techniques. Rise in awareness regarding the disease is positively impacting the market growth with increase in demand for diagnostic tests. Also, the technological developments such as molecular diagnostics involving DNA and RNA testing is contributing in the market growth.

Hence, factors such as rising awareness regarding availability of screening and monitoring procedures, growing prevalence of hepatitis and increasing demand for rapid diagnostic techniques are expected to propel the global market over the forecast period.

Further key findings from the study suggest:

• The growing prevalence rate of hepatitis (A, B, C, D & E) is primarily driving the market growth
• The blood tests segment is further segmented in to liver function tests, immunoassays & nucleic acid assays
• The blood tests dominate the market and are expected to exhibit fastest growth rate over the forecast period, owing to their affordability and higher adoption volume as compared to other tests
• The liver function tests hold a significant share of the market since these tests are the first line diagnostics and are prerequisite for further analytical examinations required to be performed for confirmation of virus causing the disease
• North America dominated in 2016, owing to rising prevalence, various government initiatives creating awareness regarding rising incidences, treatment & availability of diagnostic test options, and highly developed healthcare infrastructure
• Constant rise in the new cases of hepatitis is observed in Asia Pacific. Thus, this region is expected to witness a rapid growth during the forecast period.
• Some of the major players competing include, but are not limited to Abbott Laboratories; Danaher Corporation; F. Hoffmann Roche; DiaSorin S.p.A; MedMira, Inc.; Siemens Ag, bioMeriuex SA; Hologic, Inc.; and Bio Rad Laboratories.
• These players dominate the market with their strong brand identity and extensive geographic reach by their strategic initiatives such as mergers & acquisition and partnership with other players.

Contents

CHAPTER 1 RESEARCH METHODOLOGY

1.1 Information procurement
1.2 Data Analysis
1.3 List of Data Sources

CHAPTER 2 EXECUTIVE SUMMARY

2.1 Market Snapshot

CHAPTER 3 HEPATITIS DIAGNOSTIC MARKET VARIABLES, TRENDS & SCOPE

3.1 Market segmentation& scope
  3.1.1 Market Driver Analysis
  3.1.2 Market Restraint Analysis
3.2 Penetration & growth prospect mapping
3.3 Hepatitis Diagnostics Market - PESTLE Analysis
3.4 Industry Analysis - Porter’s

CHAPTER 4 HEPATITIS DIAGNOSTIC MARKET: TEST TYPE ESTIMATES & TREND ANALYSIS

4.1 Hepatitis diagnostics market: Tests type movement analysis
4.2 Blood Tests
  4.2.1 Blood Tests market estimates & segment forecast, 2014 - 2025 (USD Million)
  4.2.2 Liver Function Tests
    4.2.2.1 L Market estimates & segment forecast, 2014 - 2025 (USD Million)
  4.2.3 Immunoassays
    4.2.3.1 Market estimates & segment forecast, 2014 - 2025 (USD Million)
  4.2.4 Nucleic Acid Tests
    4.2.4.1 Market estimates & segment forecast, 2014 - 2025 (USD Million)
4.3 Imaging Test
  4.3.1 Market estimates & segment forecast, 2014 - 2025 (USD Million)
4.4 Liver Biopsy
  4.4.1 Market estimates & segment forecast, 2014 - 2025 (USD Million)

CHAPTER 5 HEPATITIS DIAGNOSTIC MARKET: REGIONAL ESTIMATES & TREND ANALYSIS, BY DIAGNOSTIC TESTS

5.1 Hepatitis Diagnostic market share by region, 2015 & 2024
5.2 North America
  5.2.1 North America hepatitis diagnostics market, 2014 - 2025 (USD Million)
  5.2.2 U.S.
    5.2.2.1 U.S. hepatitis diagnostics market, 2014 - 2025 (USD Million)
  5.2.3 Canada
    5.2.3.1 Canada hepatitis diagnostics market, 2014 - 2025 (USD Million)
5.3 Europe
  5.3.1 Europe hepatitis diagnostics market, 2014 - 2025 (USD Million)
  5.3.2 UK
    5.3.2.1 UK hepatitis diagnostics market, 2014 - 2025 (USD Million)
  5.3.3 Germany
    5.3.3.1 Germany hepatitis diagnostics market, 2014 - 2025 (USD Million)
5.4 Asia Pacific
  5.4.1 Asia Pacific hepatitis diagnostic market, 2014 - 2025 (USD Million)
  5.4.2 China
    5.4.2.1 China hepatitis diagnostic market, 2014 - 2025 (USD Million)
  5.4.3 Japan
    5.4.3.1 Japan hepatitis diagnostic market, 2014 - 2025 (USD Million)
5.5 Latin America
  5.5.1 Latin America hepatitis diagnostics market, 2014 - 2025 (USD Million)
  5.5.2 Brazil
    5.5.2.1 Brazil hepatitis diagnosticmarket, 2014 - 2025 (USD Million)
  5.5.3 Mexico
    5.5.3.1 Mexico hepatitis diagnostics market, 2014 - 2025 (USD Million)
5.6 MEA
  5.6.1 MEA hepatitis diagnostics market, 2014 - 2025 (USD Million)
  5.6.2 South Africa
    5.6.2.1 South Africa hepatitis diagnostics market, 2014 - 2025 (USD Million)

CHAPTER 6 COMPETITIVE LANDSCAPE

6.1 Company Profiles
  6.1.1 Siemens AG
    6.1.1.1 Company overview
    6.1.1.2 Financial performance
    6.1.1.3 Product benchmarking
    6.1.1.4 Strategic initiatives
  6.1.2 Abbott Laboratories
    6.1.2.1 Company overview
    6.1.2.2 Financial performance
    6.1.2.3 Product benchmarking
    6.1.2.4 Strategic initiatives
  6.1.3 MedMira Inc
    6.1.3.1 Company overview
    6.1.3.2 Financial performance
    6.1.3.3 Product benchmarking
    6.1.3.4 Strategic initiatives
  6.1.4 Qaigen Inc
    6.1.4.1 Company overview
    6.1.4.2 Financial performance
    6.1.4.3 Product benchmarking
    6.1.4.4 Strategic initiatives
  6.1.5 Beckman Coulter Inc (Danaher Corporation)
    6.1.5.1 Company overview
    6.1.5.2 Financial performance
    6.1.5.3 Product benchmarking
    6.1.5.4 Strategic initiatives
  6.1.6 F. Hoffmann Roche
    6.1.6.1 Company overview
    6.1.6.2 Financial performance
    6.1.6.3 Product benchmarking
    6.1.6.4 Strategic initiatives
  6.1.7 Diasorin S.p.A
    6.1.7.1 Company overview
    6.1.7.2 Financial performance
    6.1.7.3 Product benchmarking
    6.1.7.4 Strategic initiatives
  6.1.8 bioMeriuex
    6.1.8.1 Company overview
    6.1.8.2 Financial performance
    6.1.8.3 Product benchmarking
    6.1.8.4 Strategic initiatives
  6.1.9 Hologic Inc
    6.1.9.1 Company overview
    6.1.9.2 Financial performance
    6.1.9.3 Product benchmarking
    6.1.9.4 Strategic initiatives
  6.1.10 Bio-Rad Laboratories Inc
    6.1.10.1 Company overview
    6.1.10.2 Financial performance
    6.1.10.3 Product benchmarking
    6.1.10.4 Strategic initiatives

List Of Tables

LIST OF TABLES

Table 1 North America Hepatitis Diagnostics Market, by Test Type, 2014 - 2025 (USD Million)
Table 2 North America Hepatitis Diagnostics Market, by Blood Tests Market, 2014 - 2025 (USD Million)
Table 3 U.S. hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
Table 4 U.S. hepatitis diagnostics market, by blood tests, 2014 - 2025 (USD Million)
Table 5 Canada hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
Table 6 Canada hepatitis diagnostic, by blood tests, 2014 - 2025 (USD Million)
Table 7 Europe hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
Table 8 Europe hepatitis diagnostics market, by blood tests 2014 - 2025 (USD Million)
Table 9 U.K. hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
Table 10 U.K. hepatitis diagnostics market, by blood tests 2014 - 2025 (USD Million)
Table 11 Germany hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
Table 12 Germany hepatitis diagnostics market, by blood tests 2014 - 2025 (USD Million)
Table 13 Asia Pacific hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
Table 14 Asia Pacific hepatitis diagnostic market, by blood tests 2014 - 2025 (USD Million)
Table 15 China hepatitis diagnostic market, by test type, 2014 - 2025 (USD Million)
Table 16 China hepatitis diagnostic tests market, by blood tests 2014 - 2025 (USD Million)
Table 17 Japan hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
Table 18 Japan hepatitis diagnostics market, by blood tests 2014 - 2025 (USD Million)
Table 19 Latin America hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
Table 20 Latin America hepatitis diagnostic market, by blood tests 2014 - 2025 (USD Million)
Table 21 Brazil hepatitis diagnostics market, by test type , 2014 - 2025 (USD Million)
Table 22 Brazil hepatitis diagnostic market, by blood tests 2014 - 2025 (USD Million)
Table 23 Mexico hepatitis diagnostics market, by test type , 2014 - 2025 (USD Million)
Table 24 Mexico hepatitis diagnostics market, by blood tests, 2014 - 2025 (USD Million)
Table 25 MEA hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
Table 26 MEA hepatitis diagnostics market, by blood tests 2014 - 2025 (USD Million)
Table 27 South Africa hepatitis diagnostics market, by test type , 2014 - 2025 (USD Million)
Table 28 South Africa hepatitis diagnostics market, by blood test 2014 - 2025 (USD Million)

List Of Figures

LIST OF FIGURES

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market summary
Fig. 8 Market trends & outlook
Fig. 9 Market segmentation & scope
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market restraint relevance analysis (Current & future impact)
Fig. 12 Penetration & growth prospect mapping
Fig. 13 Hepatitis Diagnostic s Market PESTLE Analysis
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Hepatitis Diagnostics market drug class outlook key takeaways
Fig. 16 Hepatitis diagnostic market: test type movement analysis
Fig. 17 Blood test market estimates & segment forecast, 2014 - 2025 (USD Million)
Fig. 18 Liver function tests market estimates & segment forecast market, 2014 - 2025 (USD Million)
Fig. 19 Immunoassay market estimates & segment forecast, 2014 - 2025 (USD Million)
Fig. 20 Nucleic Tests market estimates & segment forecast, 2014 - 2025 (USD Million)
Fig. 21 Imaging test market estimates & segment forecast, 2014 - 2025 (USD Million)
Fig. 22 Liver Biopsy market estimates & segment forecast, 2014 - 2025 (USD Million)
Fig. 23 Regional market place: Key takeaways
Fig. 24 Regional outlook, 2016 & 2025
Fig. 25 North America hepatitis diagnostics market, 2014 - 2025 (USD Million)
Fig. 26 U.S. hepatitis diagnostics market, 2014 - 2025 (USD Million)
Fig. 27 Canada hepatitis diagnostics market, 2014 - 2025 (USD Million)
Fig. 28 Europe hepatitis diagnostics market, 2014 - 2025 (USD Million)
Fig. 29 UK hepatitis diagnostics market, 2014 - 2025 (USD Million)
Fig. 30 Germany hepatitis diagnostics market, 2014 - 2025 (USD Million)
Fig. 31 Asia Pacific hepatitis diagnostics market, 2014 - 2025 (USD Million)
Fig. 32 China hepatitis diagnostics market, 2014 - 2025 (USD Million)
Fig. 33 Japan hepatitis diagnostics market, 2014 - 2025 (USD Million)
Fig. 34 Latin America hepatitis diagnostics market, 2014 - 2025 (USD Million)
Fig. 35 Brazil hepatitis diagnostics market, 2014 - 2025(USD Million)
Fig. 36 Mexico hepatitis diagnostics market, 2014 - 2025 (USD Million)
Fig. 37 MEA hepatitis diagnostics market, 2014 - 2025 (USD Million)
Fig. 38 South Africa hepatitis diagnostics market, 2014 - 2025 (USD Million)
Fig. 39 Strategy framework
Fig. 40 Participant categorization